- Home
- PRE vs GNLX Comparison
PRE vs GNLX Comparison
Compare PRE & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- GNLX
- Stock Information
- Founded
- PRE 2014
- GNLX 2001
- Country
- PRE Hong Kong
- GNLX United States
- Employees
- PRE N/A
- GNLX N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- PRE Industrials
- GNLX Health Care
- Exchange
- PRE Nasdaq
- GNLX Nasdaq
- Market Cap
- PRE 120.7M
- GNLX 112.5M
- IPO Year
- PRE N/A
- GNLX 2023
- Fundamental
- Price
- PRE $7.89
- GNLX $3.44
- Analyst Decision
- PRE Buy
- GNLX Strong Buy
- Analyst Count
- PRE 1
- GNLX 4
- Target Price
- PRE $9.00
- GNLX $17.75
- AVG Volume (30 Days)
- PRE 83.8K
- GNLX 153.5K
- Earning Date
- PRE 07-22-2025
- GNLX 08-13-2025
- Dividend Yield
- PRE N/A
- GNLX N/A
- EPS Growth
- PRE N/A
- GNLX N/A
- EPS
- PRE N/A
- GNLX N/A
- Revenue
- PRE $41,520,000.00
- GNLX N/A
- Revenue This Year
- PRE $148.70
- GNLX N/A
- Revenue Next Year
- PRE $82.89
- GNLX N/A
- P/E Ratio
- PRE N/A
- GNLX N/A
- Revenue Growth
- PRE 78.72
- GNLX N/A
- 52 Week Low
- PRE $3.10
- GNLX $1.60
- 52 Week High
- PRE $11.99
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- PRE 49.68
- GNLX 65.71
- Support Level
- PRE $7.80
- GNLX $2.80
- Resistance Level
- PRE $8.29
- GNLX $3.61
- Average True Range (ATR)
- PRE 0.72
- GNLX 0.22
- MACD
- PRE -0.09
- GNLX 0.05
- Stochastic Oscillator
- PRE 19.79
- GNLX 80.23
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.